Transpire Bio Inc.
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Transpire Bio Inc. is a clinical-stage biopharmaceutical company that develops inhaled therapeutics and proprietary drug delivery platforms for respiratory and systemic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transpire Bio Inc. Comparables
Compare Transpire Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| invoX Pharma | 82% | |
| Iconovo AB | 80% | |
| Chance Pharmaceuticals | 78% | |
Transpire Bio Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 107% MoM, reaching 3.2K.
- May 2, 2025
Monthly visitors grew 253% MoM, reaching 2.4K.
Transpire Bio Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transpire Bio Inc.'s valuation, stock price, and market status.